Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for AXSM

Stock NameAxsome Therapeutics Inc
TickerAXSM(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS05464T1043
LEI549300EXGR0XLRJEIB95

Show aggregate AXSM holdings

News associated with AXSM

Peek Under The Hood: JHMM Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-19 08:11:32
Roger Jeffs Sells 13,464 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) Director Roger Jeffs sold 13,464 shares of the business’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $123.68, for a total value of $1,665,227.52. Following the completion of the sale, the director owned 57,510 shares in […] - 2025-09-04 05:23:00
Deutsche Bank AG Lowers Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Deutsche Bank AG reduced its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 21.2% during the first quarter, Holdings Channel reports. The institutional investor owned 94,980 shares of the company’s stock after selling 25,567 shares during the period. Deutsche Bank AG’s holdings in Axsome Therapeutics were worth $11,078,000 as of its […] - 2025-08-15 05:17:09
Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $189.00 at Royal Bank Of Canada
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective increased by analysts at Royal Bank Of Canada from $184.00 to $189.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective suggests a potential upside of 83.03% from the […] - 2025-08-07 05:30:53
KLP Kapitalforvaltning AS Decreases Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
KLP Kapitalforvaltning AS reduced its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 6.8% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 8,200 shares of the company’s stock after selling 600 shares during the period. KLP Kapitalforvaltning AS’s holdings in Axsome Therapeutics were worth […] - 2025-07-29 05:28:50
Cerity Partners LLC Raises Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Cerity Partners LLC lifted its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 15.5% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 5,707 shares of the company’s stock after purchasing an additional 766 shares during the period. Cerity Partners LLC’s holdings in Axsome Therapeutics were worth $666,000 as of […] - 2025-07-25 04:50:58
12,745 Shares in Axsome Therapeutics, Inc. (NASDAQ:AXSM) Acquired by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd purchased a new stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund purchased 12,745 shares of the company’s stock, valued at approximately $1,486,000. A number of other hedge funds have also recently made changes to their positions in AXSM. HighTower Advisors LLC […] - 2025-07-24 06:02:49
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by New York State Common Retirement Fund
New York State Common Retirement Fund raised its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 49.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 33,581 shares of the company’s stock after buying an additional 11,090 […] - 2025-07-22 07:13:06
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Bought by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC lifted its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 0.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,623 shares of the company’s stock after acquiring an additional 136 […] - 2025-07-17 05:39:38
D.A. Davidson & CO. Has $788,000 Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
D.A. Davidson & CO. reduced its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 17.9% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,755 shares of the company’s stock after selling 1,475 shares during the quarter. D.A. Davidson […] - 2025-07-10 05:31:08
Head-To-Head Review: Axsome Therapeutics (NASDAQ:AXSM) vs. Rosetta Genomics (OTCMKTS:ROSGQ)
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) and Rosetta Genomics (OTCMKTS:ROSGQ – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, valuation, earnings, risk and dividends. Risk and Volatility Axsome Therapeutics has a beta […] - 2025-07-07 02:28:50
Janney Montgomery Scott LLC Has $1.74 Million Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Janney Montgomery Scott LLC raised its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 8.6% in the 1st quarter, HoldingsChannel reports. The fund owned 14,923 shares of the company’s stock after buying an additional 1,178 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Axsome Therapeutics were worth $1,740,000 at the end […] - 2025-06-27 04:26:52
AXSM Makes Notable Cross Below Critical Moving Average
In trading on Monday, shares of Axsome Therapeutics Inc (Symbol: AXSM) crossed below their 200 day moving average of $102.28, changing hands as low as $101.01 per share. Axsome Therapeutics Inc shares are currently trading down about 1.9% on the day. The chart below shows the - 2025-06-16 12:41:26
GAMMA Investing LLC Increases Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
GAMMA Investing LLC increased its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 38,571.9% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 22,043 shares of the company’s stock after buying an additional 21,986 shares during the quarter. GAMMA Investing […] - 2025-06-13 05:14:47
Rhumbline Advisers Grows Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Rhumbline Advisers boosted its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 6.9% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 54,760 shares of the company’s stock after acquiring an additional 3,515 shares during the quarter. Rhumbline Advisers’ holdings in Axsome Therapeutics […] - 2025-06-12 05:31:01
HC Wainwright Reiterates “Buy” Rating for Axsome Therapeutics (NASDAQ:AXSM)
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They currently have a $180.00 target price on the stock. HC Wainwright’s price target would suggest a potential upside of 66.54% from the stock’s previous close. Several other […] - 2025-06-12 02:18:55
Needham & Company LLC Cuts Axsome Therapeutics (NASDAQ:AXSM) Price Target to $150.00
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective decreased by Needham & Company LLC from $153.00 to $150.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC’s price target would suggest a potential upside of 36.48% from the […] - 2025-06-11 02:44:51
2 Soaring Stocks Wth More Upside Potential
Although fundamental investing wisdom tells us to "buy low," it may still be worthwhile to purchase shares of top companies following significant runs. Any point can be considered low -- even after massive gains -- provided there is plenty of upside left. That brings us to Summit - 2025-06-05 04:19:00
Nuveen Asset Management LLC Increases Stock Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Nuveen Asset Management LLC raised its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 118.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 221,202 shares of the company’s stock after acquiring an additional 119,780 shares during the period. Nuveen Asset Management LLC’s holdings in Axsome Therapeutics were worth $18,716,000 as of its […] - 2025-05-25 06:03:20
Captrust Financial Advisors Sells 2,769 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Captrust Financial Advisors decreased its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 48.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 2,953 shares of the company’s stock after selling 2,769 shares during the period. Captrust Financial Advisors’ holdings in Axsome Therapeutics […] - 2025-05-22 04:47:00
Comerica Bank Sells 3,570 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Comerica Bank trimmed its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 32.6% during the 4th quarter, HoldingsChannel reports. The firm owned 7,374 shares of the company’s stock after selling 3,570 shares during the quarter. Comerica Bank’s holdings in Axsome Therapeutics were worth $624,000 at the end of the most recent reporting period. […] - 2025-05-15 04:52:49
Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $162.00
Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its target price lifted by Robert W. Baird from $160.00 to $162.00 in a report released on Tuesday, Marketbeat reports. Robert W. Baird currently has an outperform rating on the stock. Other research analysts have also recently issued research reports about the company. HC Wainwright reaffirmed a “buy” […] - 2025-05-09 03:56:43
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by Price T Rowe Associates Inc. MD
Price T Rowe Associates Inc. MD raised its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 12.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 31,228 shares of the company’s stock after acquiring an additional 3,366 shares during the period. Price T Rowe Associates […] - 2025-05-07 05:50:49
Axsome Therapeutics (NASDAQ:AXSM) Trading Up 5.6% After Earnings Beat
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report)’s stock price was up 5.6% during trading on Monday following a better than expected earnings announcement. The stock traded as high as $117.60 and last traded at $118.54. Approximately 231,459 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 683,737 […] - 2025-05-07 02:24:42
Stocks Close Lower on US Trade Policy Uncertainty
The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 10:32:49
Stocks Close Lower on US Trade Policy Uncertainty
The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 08:45:35
Stocks Close Lower on US Trade Policy Uncertainty
The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 06:31:04
Stocks Close Lower on US Trade Policy Uncertainty
The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 03:51:04
Stocks Close Lower on US Trade Policy Uncertainty
The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 02:59:18
Stocks Close Lower on US Trade Policy Uncertainty
The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 01:28:32

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc AXSM holdings

DateNumber of AXSM Shares HeldBase Market Value of AXSM SharesLocal Market Value of AXSM SharesChange in AXSM Shares HeldChange in AXSM Base ValueCurrent Price per AXSM Share HeldPrevious Price per AXSM Share Held
2025-09-26 (Friday)7,814USD 912,363USD 912,363
2025-09-25 (Thursday)7,814USD 906,502AXSM holding decreased by -21567USD 906,5020USD -21,567 USD 116.01 USD 118.77
2025-09-24 (Wednesday)7,814USD 928,069USD 928,069
2025-09-17 (Wednesday)7,764USD 905,438AXSM holding increased by 19566USD 905,4380USD 19,566 USD 116.62 USD 114.1
2025-09-16 (Tuesday)7,764USD 885,872USD 885,872
2025-09-12 (Friday)7,714USD 913,492USD 913,492
2025-09-11 (Thursday)7,714AXSM holding increased by 100USD 948,513AXSM holding decreased by -35901USD 948,513100USD -35,901 USD 122.96 USD 129.29
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AXSM by Blackrock for IE00B3VWM098

Show aggregate share trades of AXSM

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-11BUY100 122.960* 107.93
2025-08-21SELL-25 117.140* 107.87 Profit of 2,697 on sale
2025-07-31BUY75 101.380* 107.86
2025-06-30SELL-50 104.390* 107.98 Profit of 5,399 on sale
2025-06-25SELL-25 103.700* 108.08 Profit of 2,702 on sale
2025-06-20SELL-50 100.690* 108.21 Profit of 5,410 on sale
2025-05-30BUY1,235 105.160* 108.38
2025-05-23BUY21 105.070* 108.55
2025-05-19SELL-21 108.300* 108.61 Profit of 2,281 on sale
2025-05-15SELL-60 107.220* 108.64 Profit of 6,518 on sale
2025-05-12SELL-21 110.160* 108.69 Profit of 2,283 on sale
2025-05-09SELL-20 107.760* 108.70 Profit of 2,174 on sale
2025-04-30SELL-21 112.290* 108.47 Profit of 2,278 on sale
2025-04-24SELL-40 105.410* 108.52 Profit of 4,341 on sale
2025-04-17SELL-20 104.460* 108.76 Profit of 2,175 on sale
2025-04-15SELL-63 103.830* 108.86 Profit of 6,858 on sale
2025-04-14SELL-60 103.530* 108.92 Profit of 6,535 on sale
2025-04-09SELL-80 101.670* 109.27 Profit of 8,742 on sale
2025-04-07SELL-147 98.500* 109.54 Profit of 16,102 on sale
2025-04-04SELL-210 98.860* 109.66 Profit of 23,029 on sale
2025-03-31BUY21 116.630* 109.55
2025-03-19SELL-42 125.900* 108.04 Profit of 4,538 on sale
2025-03-14SELL-126 121.910* 107.36 Profit of 13,528 on sale
2025-03-13SELL-40 121.650* 107.16 Profit of 4,286 on sale
2025-03-12SELL-680 119.450* 106.98 Profit of 72,748 on sale
2025-03-07SELL-40 122.170* 106.38 Profit of 4,255 on sale
2025-03-06SELL-60 124.410* 106.11 Profit of 6,366 on sale
2025-03-03SELL-20 127.150* 105.15 Profit of 2,103 on sale
2025-02-28SELL-1,078 127.540* 104.78 Profit of 112,952 on sale
2025-02-26SELL-23 128.330* 104.01 Profit of 2,392 on sale
2025-02-25SELL-69 127.090* 103.62 Profit of 7,150 on sale
2025-02-18BUY115 128.090* 101.08
2025-02-13BUY23 131.680* 99.26
2025-02-12BUY23 131.550* 98.60
2025-02-11BUY69 132.200* 97.90
2025-02-06BUY207 109.500* 96.82
2025-01-27BUY23 102.690* 94.52
2024-12-30BUY115 84.780* 94.48
2024-12-06BUY92 100.100* 93.98
2024-12-05BUY23 98.350* 93.83
2024-12-04BUY115 99.540* 93.62
2024-11-29BUY115 98.220* 92.95
2024-11-27BUY92 99.650* 92.36
2024-11-26BUY23 97.030* 92.15
2024-11-21BUY115 98.190* 91.21
2024-11-20BUY69 94.600* 91.02
2024-11-18BUY276 92.450* 90.65
2024-11-12BUY184 99.490* 90.06
2024-11-08BUY115 90.070* 90.06
2024-11-07BUY345 90.700* 90.01
2024-11-06BUY46 90.970* 89.93
2024-10-31BUY23 89.030* 90.60
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AXSM

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1968,445300138,49249.4%
2025-09-1868,7240169,52940.5%
2025-09-1776,19740235,41232.4%
2025-09-16165,94084332,17250.0%
2025-09-1592,09146186,50049.4%
2025-09-12170,5181,480325,95252.3%
2025-09-1188,85416216,01841.1%
2025-09-1061,1600187,15532.7%
2025-09-09142,408200299,18547.6%
2025-09-08144,3200285,04950.6%
2025-09-05104,4490205,29450.9%
2025-09-0473,2161,801138,76352.8%
2025-09-03141,4770223,16563.4%
2025-09-02170,723300297,32857.4%
2025-08-2964,4241,970131,92648.8%
2025-08-2855,224200123,39944.8%
2025-08-27111,32112228,55948.7%
2025-08-26116,2050242,94147.8%
2025-08-2554,093584115,26746.9%
2025-08-22125,9940268,00847.0%
2025-08-2193,981600186,20250.5%
2025-08-20105,5440162,40265.0%
2025-08-19146,3280321,78045.5%
2025-08-18110,4110419,41026.3%
2025-08-1558,4910149,19939.2%
2025-08-1463,1170124,65350.6%
2025-08-1390,0900217,54041.4%
2025-08-1250,283920155,22232.4%
2025-08-1147,0680126,85737.1%
2025-08-0846,4790126,17936.8%
2025-08-0765,3990143,98345.4%
2025-08-06121,3540208,43958.2%
2025-08-05216,25215377,69057.3%
2025-08-04274,153551441,19662.1%
2025-08-01224,3151,925341,20365.7%
2025-07-31160,8240273,05458.9%
2025-07-30142,2479235,17960.5%
2025-07-29117,5500233,07250.4%
2025-07-28203,714708330,36561.7%
2025-07-25240,45735377,49863.7%
2025-07-24112,0065181,15561.8%
2025-07-23246,8300323,57176.3%
2025-07-22354,9990495,58971.6%
2025-07-21126,6590205,64161.6%
2025-07-18130,79415199,45865.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.